Published in

European Centre for Disease Prevention and Control, Eurosurveillance, 4(9), p. 5-6, 2004

DOI: 10.2807/esm.09.04.00456-en

Links

Tools

Export citation

Search in Google Scholar

Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2)

Journal article published in 2004 by A. Nardone ORCID, E. Miller
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Serological surveillance is an important resource to evaluate vaccine programmes, especially for diseases such as rubella, where a sub-optimal programme can lead to an increase in morbidity. A coordinated vaccine policy in Europe is needed and the aim of the European Sero-Epidemiology Network (ESEN2) is to standardise serological surveillance in 22 countries for eight diseases, including rubella.